Cypherpunk Technologies (NASDAQ:CYPH) Announces Quarterly Earnings Results

Cypherpunk Technologies (NASDAQ:CYPH) released its earnings results on Wednesday. The company reported $0.18 EPS for the quarter, FiscalAI reports.

Cypherpunk Technologies Trading Down 0.1%

Shares of NASDAQ:CYPH traded down $0.00 during mid-day trading on Thursday, reaching $0.66. The company had a trading volume of 334,876 shares, compared to its average volume of 3,274,918. Cypherpunk Technologies has a one year low of $0.23 and a one year high of $3.70. The company’s 50-day moving average price is $0.68 and its 200-day moving average price is $0.78. The firm has a market cap of $69.97 million, a price-to-earnings ratio of -32.84 and a beta of 0.09.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on CYPH shares. Cantor Fitzgerald upgraded shares of Cypherpunk Technologies to a “strong-buy” rating in a report on Friday, July 3rd. Wall Street Zen raised Cypherpunk Technologies from a “sell” rating to a “hold” rating in a research report on Saturday, July 4th. Finally, Weiss Ratings cut Cypherpunk Technologies from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Friday, July 31st. One investment analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $0.90.

Institutional Trading of Cypherpunk Technologies

Institutional investors have recently modified their holdings of the business. Millennium Management LLC purchased a new position in shares of Cypherpunk Technologies during the 4th quarter valued at $37,000. LPL Financial LLC purchased a new stake in Cypherpunk Technologies in the fourth quarter worth $38,000. Caitong International Asset Management Co. Ltd bought a new position in shares of Cypherpunk Technologies in the 4th quarter worth approximately $44,000. Sequoia Financial Advisors LLC bought a new stake in Cypherpunk Technologies during the fourth quarter worth about $56,000. Finally, HighTower Advisors LLC purchased a new stake in shares of Cypherpunk Technologies in the 4th quarter worth approximately $59,000. 30.46% of the stock is currently owned by hedge funds and other institutional investors.

About Cypherpunk Technologies

Cypherpunk Technologies Inc, previously known as Leap Therapeutics, Inc, is a company developing novel therapies for patients with cancer and implementing a digital asset treasury strategy focused on Zcash. The company’s research platform centers on modulating the tumor microenvironment to enhance anti-tumor immune responses. Cypherpunk’s proprietary pipeline includes DKN-01, a monoclonal antibody designed to neutralize Dickkopf-1 (DKK1), a protein implicated in tumor growth and immune evasion.

DKN-01 is being evaluated both as a monotherapy and in combination with checkpoint inhibitors such as pembrolizumab across multiple solid tumor indications, including gastroesophageal, pancreatic and other advanced malignancies.